8-K: Dalrada Financial Corporation's OTC Markets Status Downgraded Due to Late Filing and Auditor Change

Dalrada Financial Corporation's OTC Markets status changed to the Expert Market due to a delay in filing its annual report and a change in auditors.

Summary

• Dalrada Financial Corporation's OTC Markets status was changed to the Expert Market on January 15, 2025.
• This change is due to the delay in filing the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
• The company filed its 10-K late on January 13, 2024, due to a change in auditors.
• The initial filing was deficient because it did not include a report from the company's PCAOB registered independent public accounting firm.
• The company plans to file an amended Annual Report on Form 10-K as soon as possible, including an audit report and a footnote explaining any variances between the initial and amended filings.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the downgrade in market status, the late filing of the annual report, and the change in auditors. These factors raise concerns about the company's financial health and governance.

Positives

• Dalrada intends to rectify the deficiency by filing an amended 10-K with an audit report and variance explanations.

Negatives

• Dalrada Financial Corporation's OTC Markets status changed to the Expert Market on January 15, 2025.
• The company filed its 10-K late on January 13, 2024, due to a change in auditors.
• The initial 10-K filing on January 13, 2024, lacked a report from the company's PCAOB registered independent public accounting firm.

Risks

• The downgrade to the Expert Market could negatively impact investor confidence and trading activity.
• The delay in filing the audited financial statements raises concerns about the company's internal controls and financial reporting processes.
• Failure to file the amended 10-K promptly could result in further regulatory action or delisting.

Future Outlook

The company plans to remedy the deficiency through the filing of an amended Annual Report on Form 10-K as promptly as possible.

Management Comments

• Management believed the initial filing fairly presented the financial statements of the Company as at June 30, 2024 for the 12 months then ended, according to Alternative Reporting Standards of the OTC Markets Group Inc.

Industry Context

Companies listed on the OTC Markets are expected to adhere to certain reporting standards, and failure to do so can result in a downgrade in market status. This situation highlights the importance of timely and accurate financial reporting for maintaining investor confidence and market standing.

Comparison to Industry Standards

• Compared to companies like OTC Markets Group Inc. itself, which maintains specific standards for listed companies, Dalrada's failure to meet these standards resulted in a downgrade.
• Other companies such as those listed on the Nasdaq or NYSE are held to even higher standards of financial reporting and auditing, making Dalrada's situation a significant deviation from best practices.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment due to the downgrade in market status.
• The company's reputation may be negatively affected, potentially impacting relationships with customers and suppliers.

Next Steps

• The company plans to file an amended Annual Report on Form 10-K as promptly as possible.
• The amended report will include an audit report and a footnote explaining any variances between the initial and amended filings.

Key Dates